AZN

AstraZeneca PLC (AZN)

NYSE
$187.16
$-0.29
(-0.15%)
AstraZeneca PLC (AZN) Live Price Chart
Page last updated: 2026-02-05 22:58:00

Key Market Data

$285.75B

$187.07

$192.79

$14.98

$187.45

$-0.29

-0.15%

3M

AstraZeneca PLC (AZN) Stock Price Today

AstraZeneca PLC (AZN) is currently trading at $187.16 as of 2026-02-05 22:58:00, reflecting a -0.15% move ($-0.29) from the previous close.

In the short term, the stock has returned +9,667.93% over the past four weeks. Over the last 12 months, AstraZeneca PLC has recorded a +163.85% price change, indicating a strong performance relative to the broader market.

AstraZeneca PLC (AZN) 7-Day Stock Price Changes

Over the past seven days, AstraZeneca PLC has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $93.03 to the latest recorded price of $187.16, reflecting an intraday change of -0.15%. Daily movements highlight shifts in trading volume (2,887,906), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, AZN has delivered a +9,667.93% return over the past month and a +163.85% change in the last 12 months, indicating a strong trend relative to its broader sector peers.

How to Buy AstraZeneca PLC (AZN)

You can buy and trade AZN on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account
Step 1: Create and Verify Your MEXC Account
Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.
Step 2: Deposit Funds Into Your Account
Step 2: Deposit Funds Into Your Account
Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.
Step 3: Search for AZN and Execute Your Trade
Step 3: Search for AZN and Execute Your Trade
Open the trading page, enter AZN in the search bar, select the amount of AZN you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is AstraZeneca PLC (AZN)?

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

AstraZeneca PLC Information

Industry
--
Employees
94,300
Sector
--
Company Website

Frequently Asked Questions (FAQ)

1.What is the current share price of AstraZeneca PLC?
The latest trading price for AstraZeneca PLC (Common Stock) is $ 187.16, compared with a previous closing price of $ 187.45. That means the stock has moved -0.15% so far today. Intraday price updates and recent trading activity for AZN can be tracked on the live chart and quote section on this page.
2.Is AstraZeneca PLC stock going up or down?
Looking at recent performances, AZN has returned +9,667.93% over the past month, +152.68% over the last six months and +163.85% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe strong price momentum for AstraZeneca PLC stock, but keep in mind that past returns do not guarantee future results.
3.Where does AZN currently sit relative to its 52-week high and low?
In the most recent 52-week period, AstraZeneca PLC has traded between a low of $ 61.24 and a high of $ 192.79. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether AZN is currently nearer the top or the bottom of its one-year trading band.
4.How is AstraZeneca PLC classified by sector and industry?
AstraZeneca PLC is classified in the -- sector, within the -- industry group and the -- industry. In practice, this means AstraZeneca PLC is grouped with companies that face similar end-markets, competitive dynamics and regulatory environments. For investors, knowing AZN's sector and industry classification helps when building diversified portfolios, comparing AstraZeneca PLC with direct peers, and understanding how stock-specific risks such as -- may be influenced by broader trends in the -- sector and -- industry.
5.Where is AstraZeneca PLC listed and how large is it by market value?
AstraZeneca PLC is listed on the NYSE stock exchange in United States. Based on a market capitalization of $ 285.75B, the company is classified as a Mega-cap stock. Market cap gives a quick sense of AstraZeneca PLC's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.
6.What does AZN's EPS tell investors about its profitability?
Trailing-twelve-month EPS of -- summarises how much profit AstraZeneca PLC has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.
7.How can I track AstraZeneca PLC's financial performance over time?
To follow AstraZeneca PLC's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how AZN is performing and how the market is responding.
8.When is AstraZeneca PLC expected to report earnings?
AstraZeneca PLC's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for AZN, as they provide updated information on revenue, profitability and management's outlook.
9.What usually comes out in AstraZeneca PLC's earnings reports?
AstraZeneca PLC's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether AZN is meeting, beating or missing expectations.
10.How can I stay informed about AstraZeneca PLC's results and guidance?
You can stay up to date on AstraZeneca PLC by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for AZN on this page helps you see how new information is being reflected in the stock.
11.Does AstraZeneca PLC pay a regular cash dividend to its shareholders?
AstraZeneca PLC Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of -- at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor AZN's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.
12.What are the current dividend yield and dividend payout ratio for AZN?
Based on the latest earnings data, AZN has a dividend yield of -- and a dividend payout ratio of --. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether AstraZeneca PLC is an attractive income stock. The dividend payout ratio measures what percentage of earnings AstraZeneca PLC distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.
13.What kind of business is AstraZeneca PLC?
AstraZeneca PLC is a publicly traded company in the -- industry within the -- sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.
14.How is AZN valued in terms of P/E ratio and EPS?
AstraZeneca PLC currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of --. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of AstraZeneca PLC's earnings. Comparing AZN's P/E and EPS to those of other -- companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as AstraZeneca PLC

Largest Market Cap

See US stocks with the highest market capitalization

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

AZN-to-USD Calculator

Amount

AZN
AZN
USD
USD

1 AZN = 187.16 USD